Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on April 30, 2015, to announce its financial results for the first quarter ended March 31, 2015. The filing primarily directs investors to a press release (Exhibit 99.1) which contains detailed financial information, including both GAAP and non-GAAP measures. Management emphasizes that the non-GAAP information, which they use for internal operational and planning purposes, should be viewed as supplemental to, and not a replacement for, their GAAP-reported results.
Key Highlights
- 1Gilead Sciences announced its Q1 2015 financial results on April 30, 2015.
- 2The 8-K filing primarily serves to attach the press release containing the financial results.
- 3Both GAAP and non-GAAP financial measures for Q1 2015 and Q1 2014 are provided in the press release.
- 4Management considers non-GAAP financial information useful for investors, alongside GAAP results.
- 5Non-GAAP financial measures are used internally by Gilead for operational, budgeting, and financial planning.
- 6A reconciliation between GAAP and non-GAAP figures is available on pages 6-7 of the press release.
- 7Information furnished in this 8-K and exhibit is not considered 'filed' under Section 18 of the Exchange Act.
Frequently Asked Questions
The detailed financial results for the quarter ended March 31, 2015, are available in the press release filed as Exhibit 99.1 to this 8-K filing.
GAAP (Generally Accepted Accounting Principles) are standard accounting rules. Non-GAAP financial information is a measure that Gilead's management believes is useful for investors, often excluding certain items for internal operational and planning insights. Gilead provides a reconciliation between these measures in their press release.
No, the information provided in this Form 8-K and its attached exhibit is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. Therefore, it is not subject to the liabilities under that section.